Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Hot 100 Archives - ViewusGlobal

#hot-100 (3 Posts)

  • LE SSERAFIM Continues to Dominate the Global Billboard (Excl. U.S.) Chart for 14 Weeks LE SSERAFIM made it onto the U.S. Billboard charts. According to the latest Billboard charts, the girl group secured #147 on the Global (Excl. U.S.) chart with their third mini-album track “Smart” for 14 weeks in a row. Unlike the Hot 100 chart, which combines broadcast scores and album sales, Billboard’s Global (Excl. U.S.) chart […]
  • LE SSERAFIM Surprises Fans with Billboard Hot 100 Debut Girl group LE SSERAFIM has expressed excitement about entering the Billboard Hot 100 for the first time since its debut. The title track “EASY” from LE SSERAFIM’s (Kim Chaewon, Sakura, Huh Yunjin, Kazuha, Hong Eunchae) third mini album has ranked no.99 on the latest (as of March 9) U.S. Billboard Hot 100—the Main Song chart. […]
  • BTS Jung Kook's Long-Lasting Popularity Lands Him at 37 on Hot 100 BTS members maintain Billboard success: Jung Kook's "Seven" in the Hot 100, V's tracks, Jimin's "Like Crazy," and J-Hope's "Jack In The Box."

Must-Reads

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE